PCN66 COST-MINIMIZATION ANALYSIS OF THE USE OF RASBURICASE IN TUMOR LYSIS SYNDROME IN PEDIATRIC ONCOLOGY
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.921
https://www.valueinhealthjournal.com/article/S1098-3015(11)01060-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
392
First Page :
A166
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01060-6&doi=10.1016/j.jval.2011.02.921